BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF: 382533, 20 GA x ...

FDA Device Recall #Z-2458-2024 — Class II — June 26, 2024

Recall Summary

Recall Number Z-2458-2024
Classification Class II — Moderate risk
Date Initiated June 26, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Becton Dickinson Infusion Therapy Systems, Inc.
Location Sandy, UT
Product Type Devices
Quantity 26,400 units

Product Description

BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF: 382533, 20 GA x 1.00 in (1.1x25 mm) 63 mL/min, Rx Only. BD Insyte Autoguard BC Shielded IV Catheter is intended to be inserted into a patient's peripheral vascular system for short term use to sample blood, monitor blood pressure, or administer fluids.

Reason for Recall

Catheters may contain a hole in the catheter tubing, which could result in leakage during the insertion process.

Distribution Pattern

US: IL OUS: N/A0

Lot / Code Information

Lot # 4127714/ UDI-DI: 00382903825332

Other Recalls from Becton Dickinson Infusion Therapy Sys...

Recall # Classification Product Date
Z-2007-2025 Class II REF: 381434 BD Insyte Autoguard Shielded IV ... May 21, 2025
Z-2006-2025 Class II REF: 381923 BD Insyte Autoguard Winged Shiel... May 21, 2025
Z-2005-2025 Class II REF: 382544 BD Insyte Autoguard Shielded IV ... May 21, 2025
Z-2002-2025 Class II REF: 381433, BD Insyte Autoguard Shielded IV Ca... May 21, 2025
Z-1999-2025 Class II REF: 381423, BD Insyte Autoguard, Shielded IV C... May 21, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.